Preliminary results are in from the on-going international clinical study exploring the ability of OpsisDx to accurately identify people with multiple diseases.
Highlights:
- OpsisDx distinguishes between people with cancer, hepatitis B viral and healthy controls
- OpsisDx accurately identifies patient’s cancer tissue of origin (lung, prostate, breast, liver or colorectal)
- Hepatitis B viral infection, often linked to increased likelihood for liver cancer, is observed as a distinct category from liver cancer patients
- OpsisDx detects more stage I cancers than liquid biopsies as performed by GRAIL